Protein misfolding can trigger harmful aggregates, known as toxic protein clumps, which disrupt cellular function and drive neurodegenerative diseases like Alzheimer’s and Parkinson’s. Researchers study these clusters to develop targeted therapies, while pharmaceutical companies and biotech firms use them in drug screening. Ultimately, patients with cognitive or motor decline benefit from early diagnostics and treatments that prevent or dissolve these damaging accumulations, slowing disease progression.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends